APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dapagliflozin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dapagliflozin Tablets Market Analysis and Forecast 2026-2032

29 December 2025205 pages

Choose your research edition.

Industry ResearchDapagliflozin Tablets Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Dapagliflozin Tablets Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Dapagliflozin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dapagliflozin Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Dapagliflozin Tablets Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Dapagliflozin Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dapagliflozin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dapagliflozin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dapagliflozin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dapagliflozin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dapagliflozin Tablets include Addii Biotech, Aetos Pharma, Casca Remedies, Fawn Incorporation, Fibovil Pharma, Jabs Biotech, Rakshit Pharmaceuticals Limited, Zydus Healthcare and AstraZeneca Pharmaceuticals (China) Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dapagliflozin Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dapagliflozin Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Dapagliflozin Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dapagliflozin Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dapagliflozin Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dapagliflozin Tablets sales, projected growth trends, production technology, application and end-user industry.

Dapagliflozin Tablets Segment by Company

Addii Biotech

Aetos Pharma

Casca Remedies

Fawn Incorporation

Fibovil Pharma

Jabs Biotech

Rakshit Pharmaceuticals Limited

Zydus Healthcare

AstraZeneca Pharmaceuticals (China) Co., Ltd.

Beijing Fuyuan Pharmaceutical Co., Ltd.

Beijing Shuanglu Pharmaceutical Co., Ltd.

Chengdu Beite Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.

Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Yiling Wanzhou International Pharmaceutical Co., Ltd.

Dapagliflozin Tablets Segment by Type

10mg

5mg

Dapagliflozin Tablets Segment by Application

Hospital

Clinic

Other

Dapagliflozin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dapagliflozin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dapagliflozin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dapagliflozin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dapagliflozin Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dapagliflozin Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dapagliflozin Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dapagliflozin Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Major Manufacturers Table 3. 5mg Major Manufacturers Table 4. Global Dapagliflozin Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Dapagliflozin Tablets Industry Trends Table 9. Dapagliflozin Tablets Industry Drivers Table 10. Dapagliflozin Tablets Industry Opportunities and Challenges Table 11. Dapagliflozin Tablets Industry Restraints Table 12. Global Dapagliflozin Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dapagliflozin Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dapagliflozin Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dapagliflozin Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Dapagliflozin Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Dapagliflozin Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Dapagliflozin Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Dapagliflozin Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Dapagliflozin Tablets Sales Market Share by Region (2021-2026) Table 21. Global Dapagliflozin Tablets Sales Market Share by Region (2027-2032) Table 22. Global Dapagliflozin Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dapagliflozin Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dapagliflozin Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dapagliflozin Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dapagliflozin Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Dapagliflozin Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dapagliflozin Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dapagliflozin Tablets Manufacturers, Product Type & Application Table 30. Global Dapagliflozin Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dapagliflozin Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dapagliflozin Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dapagliflozin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dapagliflozin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dapagliflozin Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Dapagliflozin Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Dapagliflozin Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Dapagliflozin Tablets Sales Market Share by Type (2021-2026) Table 42. Global Dapagliflozin Tablets Sales Market Share by Type (2027-2032) Table 43. Global Dapagliflozin Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Dapagliflozin Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Dapagliflozin Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dapagliflozin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dapagliflozin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dapagliflozin Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Dapagliflozin Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Dapagliflozin Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Dapagliflozin Tablets Sales Market Share by Application (2021-2026) Table 54. Global Dapagliflozin Tablets Sales Market Share by Application (2027-2032) Table 55. Global Dapagliflozin Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dapagliflozin Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Addii Biotech Company Information Table 58. Addii Biotech Business Overview Table 59. Addii Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Addii Biotech Dapagliflozin Tablets Product Portfolio Table 61. Addii Biotech Recent Development Table 62. Aetos Pharma Company Information Table 63. Aetos Pharma Business Overview Table 64. Aetos Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Aetos Pharma Dapagliflozin Tablets Product Portfolio Table 66. Aetos Pharma Recent Development Table 67. Casca Remedies Company Information Table 68. Casca Remedies Business Overview Table 69. Casca Remedies Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Casca Remedies Dapagliflozin Tablets Product Portfolio Table 71. Casca Remedies Recent Development Table 72. Fawn Incorporation Company Information Table 73. Fawn Incorporation Business Overview Table 74. Fawn Incorporation Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Fawn Incorporation Dapagliflozin Tablets Product Portfolio Table 76. Fawn Incorporation Recent Development Table 77. Fibovil Pharma Company Information Table 78. Fibovil Pharma Business Overview Table 79. Fibovil Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Fibovil Pharma Dapagliflozin Tablets Product Portfolio Table 81. Fibovil Pharma Recent Development Table 82. Jabs Biotech Company Information Table 83. Jabs Biotech Business Overview Table 84. Jabs Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jabs Biotech Dapagliflozin Tablets Product Portfolio Table 86. Jabs Biotech Recent Development Table 87. Rakshit Pharmaceuticals Limited Company Information Table 88. Rakshit Pharmaceuticals Limited Business Overview Table 89. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product Portfolio Table 91. Rakshit Pharmaceuticals Limited Recent Development Table 92. Zydus Healthcare Company Information Table 93. Zydus Healthcare Business Overview Table 94. Zydus Healthcare Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Zydus Healthcare Dapagliflozin Tablets Product Portfolio Table 96. Zydus Healthcare Recent Development Table 97. AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information Table 98. AstraZeneca Pharmaceuticals (China) Co., Ltd. Business Overview Table 99. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 101. AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Development Table 102. Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information Table 103. Beijing Fuyuan Pharmaceutical Co., Ltd. Business Overview Table 104. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 106. Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Development Table 107. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information Table 108. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview Table 109. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 111. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development Table 112. Chengdu Beite Pharmaceutical Co., Ltd. Company Information Table 113. Chengdu Beite Pharmaceutical Co., Ltd. Business Overview Table 114. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 116. Chengdu Beite Pharmaceutical Co., Ltd. Recent Development Table 117. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 118. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 119. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 121. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 122. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information Table 123. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview Table 124. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 126. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Development Table 127. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information Table 128. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Business Overview Table 129. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 131. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Development Table 132. Shandong Lukang Pharmaceutical Co., Ltd. Company Information Table 133. Shandong Lukang Pharmaceutical Co., Ltd. Business Overview Table 134. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 136. Shandong Lukang Pharmaceutical Co., Ltd. Recent Development Table 137. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 138. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 139. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 141. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 142. Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information Table 143. Yiling Wanzhou International Pharmaceutical Co., Ltd. Business Overview Table 144. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 146. Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Development Table 147. North America Dapagliflozin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Dapagliflozin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 150. North America Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 151. North America Dapagliflozin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 152. North America Dapagliflozin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 153. North America Dapagliflozin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Dapagliflozin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 156. North America Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 157. North America Dapagliflozin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 158. North America Dapagliflozin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 159. North America Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Dapagliflozin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Dapagliflozin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. North America Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 164. North America Dapagliflozin Tablets Sales by Country (2027-2032) & (K Units) Table 165. North America Dapagliflozin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 166. North America Dapagliflozin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 167. United States Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 168. Canada Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 169. Mexico Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 170. Europe Dapagliflozin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Dapagliflozin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 173. Europe Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 174. Europe Dapagliflozin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Europe Dapagliflozin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Europe Dapagliflozin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Dapagliflozin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 179. Europe Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 180. Europe Dapagliflozin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Europe Dapagliflozin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Europe Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Dapagliflozin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Dapagliflozin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. Europe Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 187. Europe Dapagliflozin Tablets Sales by Country (2027-2032) & (K Units) Table 188. Europe Dapagliflozin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Europe Dapagliflozin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Germany Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 191. France Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 192. U.K. Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 193. Italy Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 194. Russia Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 195. Spain Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 198. Sweden Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 199. Poland Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 200. China Dapagliflozin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 201. China Dapagliflozin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 202. China Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 203. China Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 204. China Dapagliflozin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 205. China Dapagliflozin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 206. China Dapagliflozin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 207. China Dapagliflozin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 208. China Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 209. China Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 210. China Dapagliflozin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 211. China Dapagliflozin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Asia Dapagliflozin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Dapagliflozin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 215. Asia Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 216. Asia Dapagliflozin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 217. Asia Dapagliflozin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 218. Asia Dapagliflozin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Dapagliflozin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 221. Asia Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 222. Asia Dapagliflozin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 223. Asia Dapagliflozin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 224. Asia Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Dapagliflozin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Dapagliflozin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 228. Asia Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 229. Asia Dapagliflozin Tablets Sales by Country (2027-2032) & (K Units) Table 230. Asia Dapagliflozin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 231. Asia Dapagliflozin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 232. Japan Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 233. South Korea Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 234. India Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 235. Australia Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Dapagliflozin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Dapagliflozin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 241. SAMEA Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 242. SAMEA Dapagliflozin Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 243. SAMEA Dapagliflozin Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 244. SAMEA Dapagliflozin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Dapagliflozin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 247. SAMEA Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 248. SAMEA Dapagliflozin Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 249. SAMEA Dapagliflozin Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 250. SAMEA Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Dapagliflozin Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Dapagliflozin Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 254. SAMEA Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 255. SAMEA Dapagliflozin Tablets Sales by Country (2027-2032) & (K Units) Table 256. SAMEA Dapagliflozin Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 257. SAMEA Dapagliflozin Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 258. Brazil Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 259. Argentina Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 260. Chile Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 261. Colombia Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 262. Peru Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 264. Israel Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 265. UAE Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 266. Turkey Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 267. Iran Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 268. Egypt Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Dapagliflozin Tablets Distributors List Table 272. Dapagliflozin Tablets Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Dapagliflozin Tablets Image Figure 2. Global Dapagliflozin Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dapagliflozin Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Image Figure 5. 5mg Image Figure 6. Global Dapagliflozin Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dapagliflozin Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Dapagliflozin Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dapagliflozin Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Dapagliflozin Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dapagliflozin Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dapagliflozin Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Dapagliflozin Tablets Sales (2021-2032) & (K Units) Figure 17. Global Dapagliflozin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Dapagliflozin Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dapagliflozin Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Dapagliflozin Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Dapagliflozin Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Dapagliflozin Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Dapagliflozin Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Dapagliflozin Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dapagliflozin Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dapagliflozin Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dapagliflozin Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dapagliflozin Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Dapagliflozin Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Dapagliflozin Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dapagliflozin Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Dapagliflozin Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dapagliflozin Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dapagliflozin Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Dapagliflozin Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Dapagliflozin Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dapagliflozin Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Dapagliflozin Tablets Revenue Share by Type (2021-2032) Figure 40. North America Dapagliflozin Tablets Sales Share by Type (2021-2032) Figure 41. North America Dapagliflozin Tablets Revenue Share by Application (2021-2032) Figure 42. North America Dapagliflozin Tablets Sales Share by Application (2021-2032) Figure 43. North America Dapagliflozin Tablets Revenue Share by Country (2021-2032) Figure 44. North America Dapagliflozin Tablets Sales Share by Country (2021-2032) Figure 45. Europe Dapagliflozin Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Dapagliflozin Tablets Sales Share by Type (2021-2032) Figure 47. Europe Dapagliflozin Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Dapagliflozin Tablets Sales Share by Application (2021-2032) Figure 49. Europe Dapagliflozin Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Dapagliflozin Tablets Sales Share by Country (2021-2032) Figure 51. China Dapagliflozin Tablets Revenue Share by Type (2021-2032) Figure 52. China Dapagliflozin Tablets Sales Share by Type (2021-2032) Figure 53. China Dapagliflozin Tablets Revenue Share by Application (2021-2032) Figure 54. China Dapagliflozin Tablets Sales Share by Application (2021-2032) Figure 55. Asia Dapagliflozin Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Dapagliflozin Tablets Sales Share by Type (2021-2032) Figure 57. Asia Dapagliflozin Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Dapagliflozin Tablets Sales Share by Application (2021-2032) Figure 59. Asia Dapagliflozin Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Dapagliflozin Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Dapagliflozin Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Dapagliflozin Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Dapagliflozin Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Dapagliflozin Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Dapagliflozin Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Dapagliflozin Tablets Sales Share by Country (2021-2032) Figure 67. Dapagliflozin Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dapagliflozin Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 5mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Addii Biotech
  • Aetos Pharma
  • Casca Remedies
  • Fawn Incorporation
  • Fibovil Pharma
  • Jabs Biotech
  • Rakshit Pharmaceuticals Limited
  • Zydus Healthcare
  • AstraZeneca Pharmaceuticals (China) Co., Ltd.
  • Beijing Fuyuan Pharmaceutical Co., Ltd.
  • Beijing Shuanglu Pharmaceutical Co., Ltd.
  • Chengdu Beite Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
  • Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Yiling Wanzhou International Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dapagliflozin Tablets Market by Type
  3. 1.2.1 Global Dapagliflozin Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg
  5. 1.2.3 5mg
  6. 1.3 Dapagliflozin Tablets Market by Application
  7. 1.3.1 Global Dapagliflozin Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dapagliflozin Tablets Market Dynamics
  1. 2.1 Dapagliflozin Tablets Industry Trends
  2. 2.2 Dapagliflozin Tablets Industry Drivers
  3. 2.3 Dapagliflozin Tablets Industry Opportunities and Challenges
  4. 2.4 Dapagliflozin Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dapagliflozin Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dapagliflozin Tablets Revenue by Region
  3. 3.2.1 Global Dapagliflozin Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dapagliflozin Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Dapagliflozin Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Dapagliflozin Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dapagliflozin Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dapagliflozin Tablets Sales by Region
  9. 3.4.1 Global Dapagliflozin Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dapagliflozin Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Dapagliflozin Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Dapagliflozin Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dapagliflozin Tablets Revenue by Manufacturers
  2. 4.1.1 Global Dapagliflozin Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dapagliflozin Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dapagliflozin Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dapagliflozin Tablets Sales by Manufacturers
  6. 4.2.1 Global Dapagliflozin Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dapagliflozin Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dapagliflozin Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dapagliflozin Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dapagliflozin Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dapagliflozin Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dapagliflozin Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Dapagliflozin Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dapagliflozin Tablets Market CR5 and HHI
  16. 4.8.2 2025 Dapagliflozin Tablets Tier 1, Tier 2, and Tier 3
5 Dapagliflozin Tablets Market by Type
  1. 5.1 Global Dapagliflozin Tablets Revenue by Type
  2. 5.1.1 Global Dapagliflozin Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dapagliflozin Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dapagliflozin Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dapagliflozin Tablets Sales by Type
  6. 5.2.1 Global Dapagliflozin Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dapagliflozin Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dapagliflozin Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dapagliflozin Tablets Price by Type
6 Dapagliflozin Tablets Market by Application
  1. 6.1 Global Dapagliflozin Tablets Revenue by Application
  2. 6.1.1 Global Dapagliflozin Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dapagliflozin Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dapagliflozin Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dapagliflozin Tablets Sales by Application
  6. 6.2.1 Global Dapagliflozin Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dapagliflozin Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dapagliflozin Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dapagliflozin Tablets Price by Application
7 Company Profiles
  1. 7.1 Addii Biotech
  2. 7.1.1 Addii Biotech Company Information
  3. 7.1.2 Addii Biotech Business Overview
  4. 7.1.3 Addii Biotech Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Addii Biotech Dapagliflozin Tablets Product Portfolio
  6. 7.1.5 Addii Biotech Recent Developments
  7. 7.2 Aetos Pharma
  8. 7.2.1 Aetos Pharma Company Information
  9. 7.2.2 Aetos Pharma Business Overview
  10. 7.2.3 Aetos Pharma Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aetos Pharma Dapagliflozin Tablets Product Portfolio
  12. 7.2.5 Aetos Pharma Recent Developments
  13. 7.3 Casca Remedies
  14. 7.3.1 Casca Remedies Company Information
  15. 7.3.2 Casca Remedies Business Overview
  16. 7.3.3 Casca Remedies Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Casca Remedies Dapagliflozin Tablets Product Portfolio
  18. 7.3.5 Casca Remedies Recent Developments
  19. 7.4 Fawn Incorporation
  20. 7.4.1 Fawn Incorporation Company Information
  21. 7.4.2 Fawn Incorporation Business Overview
  22. 7.4.3 Fawn Incorporation Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fawn Incorporation Dapagliflozin Tablets Product Portfolio
  24. 7.4.5 Fawn Incorporation Recent Developments
  25. 7.5 Fibovil Pharma
  26. 7.5.1 Fibovil Pharma Company Information
  27. 7.5.2 Fibovil Pharma Business Overview
  28. 7.5.3 Fibovil Pharma Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Fibovil Pharma Dapagliflozin Tablets Product Portfolio
  30. 7.5.5 Fibovil Pharma Recent Developments
  31. 7.6 Jabs Biotech
  32. 7.6.1 Jabs Biotech Company Information
  33. 7.6.2 Jabs Biotech Business Overview
  34. 7.6.3 Jabs Biotech Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jabs Biotech Dapagliflozin Tablets Product Portfolio
  36. 7.6.5 Jabs Biotech Recent Developments
  37. 7.7 Rakshit Pharmaceuticals Limited
  38. 7.7.1 Rakshit Pharmaceuticals Limited Company Information
  39. 7.7.2 Rakshit Pharmaceuticals Limited Business Overview
  40. 7.7.3 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product Portfolio
  42. 7.7.5 Rakshit Pharmaceuticals Limited Recent Developments
  43. 7.8 Zydus Healthcare
  44. 7.8.1 Zydus Healthcare Company Information
  45. 7.8.2 Zydus Healthcare Business Overview
  46. 7.8.3 Zydus Healthcare Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zydus Healthcare Dapagliflozin Tablets Product Portfolio
  48. 7.8.5 Zydus Healthcare Recent Developments
  49. 7.9 AstraZeneca Pharmaceuticals (China) Co., Ltd.
  50. 7.9.1 AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information
  51. 7.9.2 AstraZeneca Pharmaceuticals (China) Co., Ltd. Business Overview
  52. 7.9.3 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product Portfolio
  54. 7.9.5 AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Developments
  55. 7.10 Beijing Fuyuan Pharmaceutical Co., Ltd.
  56. 7.10.1 Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Beijing Fuyuan Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  60. 7.10.5 Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Beijing Shuanglu Pharmaceutical Co., Ltd.
  62. 7.11.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  66. 7.11.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Chengdu Beite Pharmaceutical Co., Ltd.
  68. 7.12.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Chengdu Beite Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  72. 7.12.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  74. 7.13.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  75. 7.13.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  76. 7.13.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product Portfolio
  78. 7.13.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  79. 7.14 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
  80. 7.14.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  84. 7.14.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
  86. 7.15.1 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  90. 7.15.5 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Shandong Lukang Pharmaceutical Co., Ltd.
  92. 7.16.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
  93. 7.16.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
  94. 7.16.3 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  96. 7.16.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
  97. 7.17 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  98. 7.17.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  102. 7.17.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  103. 7.18 Yiling Wanzhou International Pharmaceutical Co., Ltd.
  104. 7.18.1 Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information
  105. 7.18.2 Yiling Wanzhou International Pharmaceutical Co., Ltd. Business Overview
  106. 7.18.3 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  108. 7.18.5 Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Dapagliflozin Tablets Market Size by Type
  2. 8.1.1 North America Dapagliflozin Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Dapagliflozin Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Dapagliflozin Tablets Price by Type (2021-2032)
  5. 8.2 North America Dapagliflozin Tablets Market Size by Application
  6. 8.2.1 North America Dapagliflozin Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Dapagliflozin Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Dapagliflozin Tablets Price by Application (2021-2032)
  9. 8.3 North America Dapagliflozin Tablets Market Size by Country
  10. 8.3.1 North America Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dapagliflozin Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dapagliflozin Tablets Market Size by Type
  2. 9.1.1 Europe Dapagliflozin Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dapagliflozin Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Dapagliflozin Tablets Price by Type (2021-2032)
  5. 9.2 Europe Dapagliflozin Tablets Market Size by Application
  6. 9.2.1 Europe Dapagliflozin Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dapagliflozin Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Dapagliflozin Tablets Price by Application (2021-2032)
  9. 9.3 Europe Dapagliflozin Tablets Market Size by Country
  10. 9.3.1 Europe Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dapagliflozin Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dapagliflozin Tablets Market Size by Type
  2. 10.1.1 China Dapagliflozin Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Dapagliflozin Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Dapagliflozin Tablets Price by Type (2021-2032)
  5. 10.2 China Dapagliflozin Tablets Market Size by Application
  6. 10.2.1 China Dapagliflozin Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Dapagliflozin Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Dapagliflozin Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dapagliflozin Tablets Market Size by Type
  2. 11.1.1 Asia Dapagliflozin Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dapagliflozin Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Dapagliflozin Tablets Price by Type (2021-2032)
  5. 11.2 Asia Dapagliflozin Tablets Market Size by Application
  6. 11.2.1 Asia Dapagliflozin Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dapagliflozin Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Dapagliflozin Tablets Price by Application (2021-2032)
  9. 11.3 Asia Dapagliflozin Tablets Market Size by Country
  10. 11.3.1 Asia Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dapagliflozin Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dapagliflozin Tablets Market Size by Type
  2. 12.1.1 SAMEA Dapagliflozin Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dapagliflozin Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dapagliflozin Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Dapagliflozin Tablets Market Size by Application
  6. 12.2.1 SAMEA Dapagliflozin Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dapagliflozin Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dapagliflozin Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Dapagliflozin Tablets Market Size by Country
  10. 12.3.1 SAMEA Dapagliflozin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dapagliflozin Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dapagliflozin Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dapagliflozin Tablets Value Chain Analysis
  2. 13.1.1 Dapagliflozin Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dapagliflozin Tablets Production Mode & Process
  6. 13.2 Dapagliflozin Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dapagliflozin Tablets Distributors
  9. 13.2.3 Dapagliflozin Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst